ESSA Pharma Inc. - Common Shares, no par value per share (EPIX)

Historical Holders from Q2 2018 to Q3 2025

Symbol
EPIX
CUSIP
29668H708
Type / Class
Equity / Common Shares, no par value per share
Shares outstanding
47.6M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
22.5M
Holdings value
$4.3M
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
31
Number of buys
16
Number of sells
-19
Average Value change %
0%
Average buys %
+0%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of ESSA Pharma Inc. - Common Shares, no par value per share (EPIX)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Soleus Capital Master Fund, L.P. 9.8% +94% $7.28M $3.51M 4.36M +92.8% SOLEUS CAPITAL MASTER FUND, L.P. Jul 17, 2025
BML Investment Partners, L.P. 9.5% +1.11% $6.42M $58.3K 4.22M +0.92% BML Investment Partners, L.P. Apr 24, 2025
MORGAN STANLEY 4% $457K 1.9M Morgan Stanley Sep 30, 2025
RTW INVESTMENTS, LP 2.5% $1.69M 1.11M RTW Investments, LP Dec 31, 2024

Institutional Holders of ESSA Pharma Inc. - Common Shares, no par value per share (EPIX)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 22.5M $4.3M -$19.8M $0.19 31
2025 Q2 31M $52.7M -$1.13M $1.70 35
2025 Q1 31.7M $50.1M -$2.25M $1.58 35
2024 Q4 32.8M $58.8M -$67.6M $1.79 44
2024 Q3 35.1M $213M +$270K $6.06 33
2024 Q2 35.2M $185M +$787K $5.26 32
2024 Q1 35M $297M +$2.55M $8.49 34
2023 Q4 34.8M $229M +$13.9M $6.60 30
2023 Q3 33.5M $103M +$682K $3.09 35
2023 Q2 33.2M $89.8M +$345K $2.70 37
2023 Q1 33.1M $98.3M +$349K $2.97 35
2022 Q4 33.4M $84.1M +$2.32M $2.52 42
2022 Q3 31.3M $57M -$12.2M $1.82 46
2022 Q2 37.8M $119M -$275K $3.15 55
2022 Q1 37.2M $230M -$23.2M $6.18 65
2021 Q4 36.8M $523M +$10.4M $14.20 55
2021 Q3 37.2M $297M -$67.2M $8.00 73
2021 Q2 34.2M $976M +$94.7M $28.57 77
2021 Q1 30.8M $896M +$247M $29.05 68
2020 Q4 23.1M $274M +$29M $11.93 38
2020 Q3 20.3M $139M +$43.2M $6.90 33
2020 Q2 14.1M $86.5M -$1.19M $6.20 19
2020 Q1 14.2M $56.6M +$1.34M $4.00 15
2019 Q4 13.9M $75.9M +$221K $5.50 17
2019 Q3 12.2M $40.9M +$22.6M $3.37 11
2019 Q2 5.48M $13.1M +$3.84M $2.45 6
2019 Q1 3.83M $13.1M +$209 $3.40 7
2018 Q4 3.83M $8.04M +$3.51M $2.10 6
2018 Q3 2.16M $6.52M +$3.2M $3.00 6
2018 Q2 2.75M $10.4M +$10.4M $3.78 6